zsvg-02
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 10, 2023 (NCT06113744)
Timeline
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
immunity, active - Sars-cov-2
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06113731 | Phase 2 | Jul 10, 2023 | China National Biotec Group Co., Ltd, Government of China |
| NCT06113744 | Phase 1 | Mar 10, 2023 | China National Biotec Group Co., Ltd, Government of China, Hangzhou Hospital of Traditional Chinese Medicine |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| China National Biotec Group Co., Ltd | For profit | 2 | 0 | 2 | 2023 |
| Government of China | Government | 2 | 2 | 2 | 2023 |
| Hangzhou Hospital of Traditional Chinese Medicine | Academic/Hospital | 1 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1